SELLAS Life Sciences SLS
NASDAQ SLS
$11.51 -0.08 (-0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) EBT Margin (2012 - 2022)

Updated

SELLAS Life Sciences' EBT Margin came in at -4130.10% for FY2022, down 3854.63 percentage points from -275.47% in FY2021.

Analysis

SELLAS Life Sciences (SLS) EBT Margin (2012 - 2022) Analysis & Trends

Going back to FY2013, SELLAS Life Sciences' EBT Margin data covers 5 years.

  • The FY2022 figure represents the lowest annual EBT Margin in data going back to FY2013.
  • Per Business Quant, earlier years put EBT Margin at -275.47% in FY2021 (+607.37 pp) and -882.84% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -1,673.50%
Jun 30, 2021 -234.37%
Mar 31, 2021 -39.39%
Dec 31, 2020 -218.89%
Jun 30, 2015 -268.57%
Mar 31, 2015 -324.07%
Dec 31, 2014 -303.38%
Sep 30, 2014 -652.28%
Jun 30, 2014 -698.16%
Mar 31, 2014 -545.28%
Dec 31, 2013 -1,315.68%
Sep 30, 2013 -501.73%
Jun 30, 2013 -345.60%
Mar 31, 2013 -554.76%
Sep 30, 2012 -535.13%
API Access

SELLAS Life Sciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=SLS&period=max&api_key=YOUR_API_KEY